ROIV:NASDAQ
Roivant Sciences Ltd
$39.77
arrow_downward
-0.53%(-0.21) 1D
$39.77
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ROIV...
Open
$40.11
High
$40.71
Low
$39.72
Mkt. cap
28.73B
Avg. vol.
8.15M
Volume
32.20M
52-wk high
$42.50
52-wk low
$14.50
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
Open
$40.11
High
$40.71
Low
$39.72
Mkt. cap
28.73B
Avg. vol.
8.15M
Volume
32.20M
52-wk high
$42.50
52-wk low
$14.50
EPS
-$0.39
Beta
1.12
Shares outstanding
722.32M
No. of employees
721
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
ROIV Q2 2026 Earnings: Loss Narrows More Than Expected, Yet Shares Slip - Margin Expansion Trends
CarePlus VietNam
·
1 month ago
Roivant Sciences (ROIV) Edges Lower as Stock Consolidates Near Support Zone - Triple Bottom
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd